Development and Validation of Pediatric Narcolepsy Patient Reported Outcomes Scale
PN-PROS
1 other identifier
observational
212
1 country
1
Brief Summary
The purpose of this study is to test a pediatric narcolepsy patient reported outcomes tool to assess pediatric narcolepsy symptoms and their effect on daily functioning and quality of life. The goal is to develop a clinical survey that can improve the care of pediatric narcolepsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 2, 2019
CompletedFirst Submitted
Initial submission to the registry
May 10, 2022
CompletedFirst Posted
Study publicly available on registry
May 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedFebruary 13, 2025
February 1, 2025
5.2 years
May 10, 2022
February 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Survey Validation
To evaluate the content validity and reliability of the PN-PROs item pools through a field test of the item pools in a diverse, national sample of pediatric narcolepsy patients with a comparator group of pediatric mild obstructive sleep apnea patients (9-17 years).
2 Years
Study Arms (2)
Narcolepsy
Narcolepsy type 1 (NT1 or narcolepsy with cataplexy) and Narcolepsy type 2 (NT2 or narcolepsy without cataplexy)
Obstructive Sleep Apnea
mild to moderate obstructive sleep apnea (OSA; obstructive AHI of 1-15/hour)
Eligibility Criteria
Patients (and a parent/guardian) with an established narcolepsy type 1, narcolepsy type 2, or OSA diagnoses ages 9-17 years.
You may qualify if:
- Children and adolescents ages 9-17
- Have a diagnosis of narcolepsy type 1, narcolepsy type 2, or mild to moderate obstructive sleep apnea (OSA)
You may not qualify if:
- A history of visual or hearing impairment
- A co-morbid neurodevelopmental disorder such as autism or schizophrenia
- No access to computer/tablet/smart phone to complete questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- National Jewish Healthcollaborator
- Geisinger Cliniccollaborator
- The Hospital for Sick Childrencollaborator
- Stanford Universitycollaborator
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kiran Maski, MD, MPH
Boston Children's Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 10, 2022
First Posted
May 13, 2022
Study Start
April 2, 2019
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
February 13, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
No individual participant data will be shared with other researchers outside of Boston Children's Hospital.